Accurate Classification System for Patients With COVID-19 Pneumonitis

Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04302688

Enrollment

669

Registered

2020-03-10

Start date

2019-12-10

Completion date

2020-03-04

Last updated

2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonitis

Brief summary

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Detailed description

1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group. 2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility. 3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.

Exclusion criteria

* Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia. * Suspected patient review refers to the negative nucleic acid test.

Design outcomes

Primary

Measure	Time frame	Description
survival status	10 December 2019 to 10 February 2020	survival status as of February 24, 2020

Countries

China

Outcome results